Page last updated: 2024-08-24

imiquimod and Hypomelanosis

imiquimod has been researched along with Hypomelanosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edgar, N; Hogan, DJ; Pilkington, S1
Akasaka, T; Mori, S1
Long, FQ; Qian, YH; Zhao, LS1
Godbolt, A; Sriprakash, K1
Ahn, JH; Hwang, HS; Kang, HY; Kang, SU; Kim, CH; Lee, MH; Pyun, JH1
Burnett, CT; Kouba, DJ1
Brown, T; Cotsarelis, G; Gelfand, JM; Zirvi, M1
Mendonça, CO; Yates, VM1
Blyumin, M; Jacob, SE1

Reviews

2 review(s) available for imiquimod and Hypomelanosis

ArticleYear
Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
    The Australasian journal of dermatology, 2009, Volume: 50, Issue:3

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Hypopigmentation; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Vitiligo

2009
Imiquimod-induced depigmentation: report of two cases and review of the literature.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:11

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Skin Neoplasms; Vitiligo

2012

Other Studies

7 other study(ies) available for imiquimod and Hypomelanosis

ArticleYear
Imiquimod-induced hypopigmentation following treatment of periungual verruca vulgaris.
    Cutis, 2018, Volume: 101, Issue:6

    Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Paronychia; Skin Diseases, Viral; Warts

2018
Imiquimod-induced vitiligo-like hypopigmentation after treatment for radiation keratosis.
    Clinical and experimental dermatology, 2016, Volume: 41, Issue:8

    Topics: Adjuvants, Immunologic; Aminoquinolines; Dermatologic Agents; Humans; Hypopigmentation; Imiquimod; Keratosis; Male; Middle Aged; Radiation Injuries

2016
Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
    Chinese medical journal, 2017, 02-20, Volume: 130, Issue:4

    Topics: Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Vitiligo

2017
Imiquimod induces apoptosis of human melanocytes.
    Archives of dermatological research, 2010, Volume: 302, Issue:4

    Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Caspase 3; Cells, Cultured; Humans; Hypopigmentation; Imiquimod; In Situ Nick-End Labeling; Melanocytes; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Vitiligo

2010
Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts.
    Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:4

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Genital Diseases, Male; Humans; Hypopigmentation; Imiquimod; Male

2005
Permanent facial hypopigmentation following treatment with imiquimod cream.
    Clinical and experimental dermatology, 2006, Volume: 31, Issue:5

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Humans; Hypopigmentation; Imiquimod; Male; Steroids; Treatment Outcome

2006
Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:6

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Hypopigmentation; Imiquimod; Male; Skin Neoplasms; Thorax

2008